{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:04:45Z","timestamp":1790741085106,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T00:00:00Z","timestamp":1411862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.atherosclerosis.2014.09.022","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T22:40:17Z","timestamp":1412376017000},"page":"645-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-0029","authenticated-orcid":false,"given":"Sophie","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Alm\u00e9ras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-0804","authenticated-orcid":false,"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Deshaies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Despr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2014.09.022_bib1","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1038\/oby.2006.281","article-title":"Metabolic syndrome: focus on dyslipidemia","volume":"14","author":"Ginsberg","year":"2006","journal-title":"Obes. (Silver Spring)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.09.022_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.022_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/diabetes.52.1.172","article-title":"The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat","volume":"52","author":"Nieves","year":"2003","journal-title":"Diabetes"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2014.09.022_bib4","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2014.09.022_bib5","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1002\/j.1550-8528.1998.tb00683.x","article-title":"The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk","volume":"6","author":"Despres","year":"1998","journal-title":"Obes. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.022_bib6","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Seppala-Lindroos","year":"2002","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.09.022_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.09.022_bib8","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1210\/jc.2009-0875","article-title":"The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity","volume":"94","author":"Arafat","year":"2009","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2014.09.022_bib9","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/MCB.01011-12","article-title":"Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling","volume":"32","author":"Shen","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2014.09.022_bib10","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1074\/jbc.M110.193334","article-title":"The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton","volume":"286","author":"Kawai","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.09.022_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.09.022_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-0030-1262854","article-title":"Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity","volume":"42","author":"Li","year":"2010","journal-title":"Horm. Metab. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.022_bib13","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/oby.2012.90","article-title":"Upregulation of plasma insulin-like growth factor binding protein 2 levels after biliopancreatic diversion in humans","volume":"20","author":"Li","year":"2012","journal-title":"Obes. (Silver Spring)"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.09.022_bib14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s10552-010-9610-x","article-title":"The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (prostate testing for cancer and treatment) study","volume":"21","author":"Rowlands","year":"2010","journal-title":"Cancer Causes Control CCC"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.09.022_bib15","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1210\/jc.2006-0745","article-title":"Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort","volume":"91","author":"Martin","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.022_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2006-924320","article-title":"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome","volume":"114","author":"Heald","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diab. Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.09.022_bib17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1210\/jc.2009-1508","article-title":"Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age","volume":"95","author":"de Kort","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.09.022_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/db06-0436","article-title":"IGF-binding protein-2 protects against the development of obesity and insulin resistance","volume":"56","author":"Wheatcroft","year":"2007","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.09.022_bib19","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1210\/endo.140.12.7169","article-title":"Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain","volume":"140","author":"Hoeflich","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.022_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell. Metab."},{"issue":"Pt 4","key":"10.1016\/j.atherosclerosis.2014.09.022_bib21","first-page":"468","article-title":"Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes","volume":"51","author":"Narayanan","year":"2013","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.09.022_bib22","first-page":"187","article-title":"Techniques for the measurement of visceral fat: a practical guide","volume":"17","author":"van der Kooy","year":"1993","journal-title":"Int. J. Obes. Relat. Metab. Disord. : J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.atherosclerosis.2014.09.022_bib23","series-title":"Anthropometric Standardization Reference Manual","year":"1988"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.09.022_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1079\/BJN19890104","article-title":"Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements","volume":"61","author":"Ferland","year":"1989","journal-title":"Br. J. Nutr."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.09.022_bib25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2014.09.022_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0009-8981(60)90075-9","article-title":"On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins","volume":"5","author":"Burstein","year":"1960","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.09.022_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.09.022_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0026-0495(87)90183-1","article-title":"Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma","volume":"36","author":"Moorjani","year":"1987","journal-title":"Metab. Clin. Exp."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.022_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00365518709168939","article-title":"Immunoturbidimetric determination of apolipoproteins A-1 and B in serum","volume":"47","author":"Riepponen","year":"1987","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.09.022_bib30","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00125-004-1585-2","article-title":"Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women","volume":"47","author":"Blackburn","year":"2004","journal-title":"Diabetologia"},{"issue":"11\u201312","key":"10.1016\/j.atherosclerosis.2014.09.022_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF02395514","article-title":"Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis","volume":"26","author":"Cheng","year":"1988","journal-title":"Biochem. Genet."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.09.022_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0022-2275(20)31585-6","article-title":"A\u00a0new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma","volume":"42","author":"Perusse","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.022_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.09.022_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.09.022_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0889-7204.2003.02910.x","article-title":"New guidelines for low-density lipoprotein levels from the National Cholesterol Education Program (NCEP): a 2004 update","volume":"19","author":"Brown","year":"2004","journal-title":"Prog. Cardiovasc. Nurs."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.09.022_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.09.022_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/dmr.5610030208","article-title":"Lipoprotein lipase in diabetes","volume":"3","author":"Taskinen","year":"1987","journal-title":"Diab. Metab. Rev."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.022_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/db10-0867","article-title":"Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?","volume":"60","author":"McQuaid","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.09.022_bib40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.22565","article-title":"Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins","volume":"48","author":"Qiu","year":"2008","journal-title":"Hepatology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T22:42:21Z","timestamp":1650321741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014014245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0021915014014245"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}